Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

OBJECTIVE: To compare the effect of sitagliptin (100 mg) vs glimepiride (1–3 mg) as add-on therapy in Indian type 2 diabetes (T2DM) patients on treatment with insulin and metformin (SWIM study). RESEARCH DESIGN AND METHODS: This 24-week, controlled, open-label study randomized T2DM patients (n = 440...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocr Connect
Main Authors: Kesavadev, Jothydev, Pillai, Pradeep Babu Sadasivan, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
Formato: Artigo
Idioma:Inglês
Publicado em: Bioscientifica Ltd 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5670271/
https://ncbi.nlm.nih.gov/pubmed/28982699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-17-0100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados